Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial

The Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (TRANSCEND) Investigators

    Research output: Contribution to journalArticlepeer-review

    864 Citations (SciVal)

    Fingerprint

    Dive into the research topics of 'Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial'. Together they form a unique fingerprint.

    Pharmacology, Toxicology and Pharmaceutical Science